Literature DB >> 7304603

Effect of chemical modification of sulfhydryl groups of human erythrocyte enzymes.

W N Valentine, D E Paglia.   

Abstract

Erythrocyte lysate proteins by five methods were chemically modified by methanethiolation with methyl methanethiolsulfonate (MMTS). This relatively newly studied agent delivers the small uncharged, non-hydrogen-bonding CH3S-group to accessible -SH groups under mild conditions. Glycolytic and nonglycolytic red cell enzymes studied could be grouped into four categories based on degree of catalytic inhibition by MMTS, which ranged from 100% to nil. NADH ((0.06 mM) protected against lactate dehydrogenase (LDH) inhibition nearly completely, and partial protection was evident at 1 microM concentrations. NAD was virtually ineffective at comparable molarities, and pyruvate failed to protect significantly. Glucose-6-phosphate dehydrogenase (G-6-PD) (but not 6-PGD) was protected by NADP (but minimally if at all by NADPH) at low molarities. Substrate G-6-P failed to protect. Mg++ alone protected enolase to a major degree against MMTS inhibition. Residual activities of several enzymes were rendered highly unstable to thermal stress, and in the case of selected enzymes, alteration of pH activity curves and catalytic activity at diminished substrate concentration was demonstrable. The highly specific modification of sulfhydryl groups of cysteinyl residues under mild conditions preserving other aspects of enzyme structure provides insights into the role of these most reactive of all amino side-chains in the enzyme proteins derived from human red cell lysates.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7304603     DOI: 10.1002/ajh.2830110202

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  1 in total

1.  Modification of erythrocyte enzyme activities by persulfides and methanethiol: possible regulatory role.

Authors:  W N Valentine; J I Toohey; D E Paglia; M Nakatani; R A Brockway
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.